Citius Pharmaceuticals In... (CTXR)
NASDAQ: CTXR
· Real-Time Price · USD
0.87
0.01 (1.66%)
At close: Jun 06, 2025, 3:59 PM
0.82
-5.13%
After-hours: Jun 06, 2025, 04:33 PM EDT
1.66% (1D)
| Bid | 0.82 |
| Market Cap | 8.92M |
| Revenue (ttm) | 155.93K |
| Net Income (ttm) | -42.64M |
| EPS (ttm) | -5.76 |
| PE Ratio (ttm) | -0.15 |
| Forward PE | 1.01 |
| Analyst | Buy |
| Ask | 0.94 |
| Volume | 95,612 |
| Avg. Volume (20D) | 302,709 |
| Open | 0.85 |
| Previous Close | 0.86 |
| Day's Range | 0.81 - 0.87 |
| 52-Week Range | 0.65 - 26.25 |
| Beta | 0.85 |
About CTXR
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CTXR
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CTXR stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 weeks ago
-11.74%
Citius Pharmaceuticals shares are trading lower af...
Unlock content with
Pro Subscription
2 months ago
-19.46%
Citius Pharmaceuticals shares are trading lower after the company announced a $2 million registered direct offering of common stock
10 months ago · newsfilecorp.com
Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com, a go-to investing platform releases the second of a two-part series looking at biotech/biopharma ...
11 months ago · newsfilecorp.com
Biopharma Stocks Transformative Innovation for the Future of HealthVancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the first of a two-part series looking at transformative innov...
